What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: A review of the literature

International Forum of Allergy and Rhinology

Volumn 2, Issue 2, 2012, Pages 95-103

  Poetker, David M ^a   Smith, Timothy L ^b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adrenal cortex hormones; Informed consent; Jurisprudence; Malpractice; Steroids

Indexed keywords

CORTICOSTEROID; PREDNISONE; STEROID;

ACNE; AVASCULAR NECROSIS; CATARACT; CORTICOSTEROID THERAPY; DOCTOR PATIENT RELATION; DRUG MEGADOSE; FRACTURE; GLAUCOMA; HAIR GROWTH; HORMONE SYNTHESIS; HUMAN; INFORMED CONSENT; JURISPRUDENCE; LAW SUIT; MALPRACTICE; MEDICAL INFORMATION; MEDICATION ERROR; MEDICOLEGAL ASPECT; MENSTRUAL IRREGULARITY; OSTEOPOROSIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN BRUISING; TREATMENT DURATION; WEIGHT GAIN; WOUND HEALING IMPAIRMENT;

ADRENAL CORTEX HORMONES; COMMUNICATION; HUMANS; INFORMED CONSENT; MALPRACTICE; PHYSICIAN-PATIENT RELATIONS; RHINITIS; RISK; SINUSITIS;

EID: 84862856165     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21016     Document Type: Review

References (30)

1. Dubin MG, Liu C, Lin SY, Senior BA. American Rhinologic Society member survey on "maximal medical therapy "for chronic rhinosinusitis. Am J Rhinol. 2007;21:483-488.
2. Cope D, Bova R. Steroids in otolaryngology. Laryngoscope. 2008;118:1556-1560.
3. Nadel DM. The use of systemic steroids in otolaryngology. Ear Nose Throat J. 1996;75:502-505, 509-510, 511-512 passim.
4. Poetker DM, Reh, DD. A comprehensive review of the adverse effects of corticosteroids. Otolaryngol Clin North Am. 2010;43:753-768.
5. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults. Frequency, screening and prevention. Drug Saf. 2007;30:861-881.
6. Nash JJ, Nash AG, Leach ME, Poetker DM. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg. 2011;144:10-15.
7. Keenan GF. Management of complications of glucocorticoid therapy. Clin ChestMed. 1997;18:507-520.
8. Cui Q, Wang G-J, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054-1063.
9. Mirzai R, Chang C, Greenspan A, GershwinME. The pathogenesis of osteonecrosis and the relationship to corticosteroids. J Asthma. 1999;36:77-95.
10. Richard RN. Short-term corticosteroids and avascular necrosis: medical and legal realities. Cutis. 2007;80:343-348.
11. McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001;164:205-206.
12. Wong GK, Poon WS, Chiu KH. Steroid-induced avascular necrosis of the hip in neurosurgical patients: epidemiological study. ANZ J Surg. 2005;75:409-410.
13. Brick DC. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol. 1995;40:232-236.
14. CraneM. The medication errors that get doctors sued. Med Econ. 1993;22:36-38,40-41.
15. Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW. Analysis of medicationrelated malpractice claims. Arch Intern Med. 2002;162:2414-2420.
16. Bettman JW. Seven hundred medicolegal cases in ophthalmology. Ophthalmology. 1990;97:1379-1384.
17. Carter RM. Malpractice and avascular necrosis: legal outcomes. Can J Gastroenterol. 1999;13:79-84.
18. Lal D, Hwang PH. Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review. Int Forum Allergy Rhinol. 2011;1:136-143.
19. Ward TN, Allen WR. Case 3: the steroid complication. Headache. 2008;48:866-870.
20. Rado SG. A patient's right to know: a case for mandating disclosure of physician success rate as an element of informed consent. Health Matrix Clevel. 2008;18:501-530.
21. Freishtat HW. View from the nation's courts. Informed consent: how little is too little? J Clin Psychopharmacol. 1986;6:110-111.
22. Curran WJ, Hyg SM. Informed consent in malpractice cases. A turn toward reality. N Engl J Med. 1986;314:429-431.
23. Lim CS, Miles J, Peckham TJ. Current practice of obtaining informed consent for local steroid injection among the shoulder and elbow surgeons in United Kingdom. Scott Med J. 2010;55:32-34.
24. Hissaria P, Smith W, Wormold PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebocontrolled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128-133.
25. Beńi{dotless}tez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116:770-775.
26. Sachanandani NS, Piccirillo JF, Kramper MA, et al. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2009;135:303-307.
27. Welch KC, Thaler ER, Doghramji LL, Palmer JN, Chiu AG. The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy. 2010;24:26-28.
28. Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology. 1993;31:183-184.
29. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:S35- S40.
30. Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy. 2009;23:40-45.